arrow
D

Dorota Iwaszkiewicz-Grześ

Medical University Gdańsk
H指数:14
被引数:712

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of the therapy with CD4+CD25highCD127-T regulatory cells: When paediatric patient becomes adult

CD4+CD25highCD127-T调节性T细胞疗法的安全性与有效性:当儿科患者转变为成人

2025-11-010
OAAI
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration

通过改善调节性T细胞抑制活性,PD-1受体 () t细胞与调节性t细胞和利妥昔单抗联合治疗1型糖尿病儿童的疗效相关

2024-05-010
PRE
Combined therapy with CD4+CD25highCD127-T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial

CD4 CD25highCD127-T调节细胞和anti-CD20抗体联合治疗新发1型糖尿病优于单药治疗: 随机I/II期试验

2022-05-0926
PRE
Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study
2021-01-0539
PREAI
Combined Immunotherapy with T Regulatory Cells and Anti-CD2O Antibody Prolongs Survival of Pancreatic Islets in Type 1 Diabetes
2020-06-014
PRE
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy

胰岛素原特异性T调节细胞可能控制1型糖尿病的免疫反应: 对过继治疗的影响

2020-02-2414
OAAI
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses (vol 8, 1870, 2017)
2018-02-222
OAAI
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

关于调节性T细胞的最低信息: 迈向可重复性和标准化的一步

2018-01-1556
OAAI
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

影响1型糖尿病患者调节性T细胞治疗长期疗效的因素

2016-12-0185
OAAI